PsychedelicNewsBreaks

TuesdayApr 10, 2018 2:43 pm

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Delivers Comprehensive Suite of Services to the Hemp and Cannabis Markets

As hemp cultivation in America continues to rise, Marijuana Company of America (OTC: MCOA) is providing a variety of hemp-derived CBD products as well as turnkey services for marketers and growers. An article discussing the company reads: “Through wholly owned subsidiary hempSMART™, MCOA is bringing high quality CBD-based products derived from industrial hemp to market through its affiliate marketing program. Its patent-pending product, hempSMART Brain, provides safe and effective support of healthy brain function, while its recently launched HempSMART DROPS is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The company recently debuted its new encapsulate product,…

Continue Reading

FridayApr 06, 2018 3:29 pm

PsychedelicNewsBreaks – EVIO, Inc. (EVIO) Cannabis Testing Services Ensure Safety, Analyze Potency

EVIO (OTCQB: EVIO), a life sciences and cannabis testing company, provides laboratory testing to ensure that consumers receive products that meet stringent standards of healthful quality. An article discussing the company’s services reads: “The company plans to reach a total of 18 laboratories in the United States by the end of the year. In the meantime, clients can bring plant samples into the Oregon-based company’s labs in California or four other states along the East and West Coasts or ask a lab representative to make an on-site visit for random sampling. The lab will visually inspect the plants for signs…

Continue Reading

ThursdayMar 29, 2018 12:35 pm

PsychedelicNewsBreaks – Earth Science Tech, Inc. (ETST) Expands Presence in Blossoming Hemp-Based CBD Market

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, is on track to increase growth and broaden its presence in the cannabis industry. An article discussing the company reads: “The worldwide cannabidiol (CBD) oil market, which includes products derived from both marijuana and hemp, is projected to grow at a CAGR of more than 39 percent through 2021. The health benefits of CBD oil are the major driver for growth in this market, with global demand steadily on the rise in recent years. Hemp-based CBD oil products in particular are more…

Continue Reading

FridayMar 23, 2018 12:09 pm

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers a Natural Option for Pet Owners with hempSMART Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) recently launched its new CBD-based natural pet product, hempSMART™ Full Spectrum Pet Drops. An article discussing the company’s new pet product line reads: “MCOA’s hempSMART™ Full Spectrum Pet Drops for cats and dogs are formulated with 250mg of full spectrum non-psychoactive cannabidiol (CBD) derived from industrial hemp. The new, specially-formulated product contains naturally-occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor that pets will love. The new Full Spectrum Pet Drops add a new vertical to MCOA’s fast growing…

Continue Reading

ThursdayMar 22, 2018 10:41 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Receives Notice of Allowance from United States Patent and Trademark Office

Drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced that it has received a new Notice of Allowance from the United States Patent and Trademark Office ("USPTO") covering "composition of matter" claims which protect the specific combination of substances that enables improved taste and the bioabsorption properties of its DehydraTECH™ technology for the delivery of cannabinoids. The newly-granted patent is a substantial addition to Lexaria's previously granted manufacturing method of use patent. In accordance with USPTO practice, there is no opposition period between allowance and issuance. The patent application number is 15/225,802 titled, "Food and…

Continue Reading

MondayMar 05, 2018 2:41 pm

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers Hemp-based CBD Products through its hempSMART Line

Innovative hemp and cannabis corporation Marijuana Company of America’s (OTC: MCOA) hempSMART product line continues to deliver new industrial hemp-based CBD products to consumers. An article discussing the company reads: “MCOA delivers turnkey products and services to consumers in U.S. states where the cannabis plant’s derivatives have been legalized. While federal drug policy continues to target state-by-state normalization of cannabis for medicinal and recreational use, MCOA’s hempSMART subsidiary is turning out branded products containing industrial hemp-derived, non-psychoactive cannabidiol (CBD) formulations for retail distribution via an affiliate marketing model.” To view the full article, visit http://cnw.fm/9HayA About Marijuana Company of America,…

Continue Reading

MondayFeb 26, 2018 9:29 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Global Licensing Agreement with Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF)

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said it has entered an agreement with NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) resulting in NeutriSci now having 100% ownership of Ambarii Trade Corporation. Lexaria has also granted to NeutriSci an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. Per the License Agreement, NeutriSci will remain focused on the development and sales of its existing and pipeline products that include Lexaria's technology for enhancing palatability and bioavailability of beneficial non-psychoactive cannabinoids. Lexaria will receive continuing royalty revenues from the sales generated by these products.…

Continue Reading

TuesdayFeb 20, 2018 9:56 am

PsychedelicNewsBreaks – Marijuana Company of America, Inc. (MCOA) Expands hempSMART™ Line with Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the release of hempSMART™ Full Spectrum Pet Drops, a natural product line formulated with 250mg of full spectrum non-psychoactive cannabidiol (“CBD”) derived from industrial hemp. Per the update, in addition to naturally-occurring CBD, the specially-formulated product contains full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor. “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health,” Donald Steinberg, CEO of MCOA, stated in the news release. “Our…

Continue Reading

ThursdayFeb 15, 2018 3:10 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Utilizes Oral Digestion Technology to Expand Product Line

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently announced its entry into a licensing agreement with Cannfections Group Inc. The agreement offers Lexaria the ability to provide commercial clients with high quality chocolate edibles using its proprietary DehydraTECH™ oral digestion technology. An article discussing the company reads: “Lexaria has developed various products for demonstration, testing and sales, showing wide applicability. These non-psychoactive cannabinoid products have a high-absorption hemp oil formula, are an excellent source of omegas and essential fatty acids and are engineered for physiological performance and recovery. APIs within Lexaria’s products have been shown to reduce anxiety and stress while…

Continue Reading

MondayJan 29, 2018 11:38 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates. The company has been working with the National Research Council of Canada (“NRC”), an agency of the Canadian federal government, to explore the effects of its technology. Lexaria’s superior delivery system…

Continue Reading